News & Updates
Filter by Specialty:
Study supports early antibiotic suspension in kids with cancer, febrile neutropenia
The E-STOP trial presented at ESHRE 2025 supports early antibiotic suspension in paediatric patients with cancer and febrile neutropenia (FN).
Study supports early antibiotic suspension in kids with cancer, febrile neutropenia
14 Aug 2025
HBV vaccination, HIV PEP compliance low among young sexual assault victims
Many paediatric sexual assault victims do not receive hepatitis B virus (HBV) postexposure vaccination and have low compliance to HIV postexposure prophylaxis (PEP), reveals a study in Singapore.
HBV vaccination, HIV PEP compliance low among young sexual assault victims
11 Aug 2025
Lenacapavir serves its PURPOSE in young individuals
Twice-yearly subcutaneous (SC) lenacapavir demonstrates high efficacy, favourable safety, and consistent pharmacokinetics (PK) as pre-exposure prophylaxis (PrEP) for HIV-negative youth (aged 16–25 years) in an analysis of the phase III PURPOSE 1 (P1) and PURPOSE 2 (P2) trials.
Lenacapavir serves its PURPOSE in young individuals
11 Aug 2025
Antibiotics use after RARC lowers 90-day UTIs, complications
The use of antibiotic therapy for 30 days following robot-assisted radical cystectomy (RARC) results in reduced 90-day urinary tract infections (UTIs), infectious complications, UTI-related readmissions, and costs without an increase in adverse events (AEs), a study has shown.